Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial.

待确认 10 由士多啤梨发布于 2026/6/29 17:06:17

DOI:DOI :10.1016/S2213-2600(21)00134-X
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/S2213-2600(21)00134-X

Elsevier

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

6小时前

哈利波特的发光魔杖耶

4fec8c59739b11f1bc9b34735aa3bc31.pdf

6小时前

Book学术机器人

2026/6/29 17:06:17 未找到该文献，机器人已退出，请等待人工下载

2026/6/29 17:06:17 Book学术AI机器人收到请求，开始寻找文献

2026/6/29 17:06:17 已向机器人发送请求

6小时前

士多啤梨发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Royal Society of Chemistry (RSC)A unified UPLC-MS/MS method for simultaneous quantification of intact anthocyanins and their metabolites in rat plasma